A coronavirus-focused linkfest is for now a weekly feature here on Abnormal Returns. Please stay safe and find a vaccination site near you. You can read last week’s edition here.
Quote of the Day
"(T)he U.S. didn’t beat the coronavirus by locking people up in their homes against their will, but by inventing new technology that let them live their lives as they wish."
(Ben Thompson)
Vaccines
- As it stand today, the Novavax ($NVAX) vaccine looks like the best option, all around. (theatlantic.com)
- Moderna ($MRNA) is upping its production capacity, in part, to produce booster shots. (wsj.com)
- What researchers hope to learn from the failure of the CureVac mRNA vaccine. (scientificamerican.com)
- The risk of infection drops sharply 21 days after your first vaccination. (newscientist.com)
- Why fractional dosing would double vaccine availability. (marginalrevolution.com)
Vaccine distribution
- Nearly all Covid deaths in the U.S. are now among the unvaccinated. (apnews.com)
- It's going to take boots on the ground to reach unvaccinated populations. (reasonstobecheerful.world)
- Some colleges are waiting for full approval of the vaccine to make it a requirement. (washingtonpost.com)
- Some 99.6% of Houston Methodist employees chose to get vaccinated. (washingtonpost.com)
Mix and match
- Why your booster shot may be of a different manufacturer. (businessinsider.com)
- How mixing and matching vaccines could help fight variants. (fastcompany.com)
Delta variant
- The Delta variant is gaining share in the U.S. (cnbc.com)
- How the Delta variant could affect the economies of states that are lagging on vaccinations. (econbrowser.com)
- The Delta variant is spreading across Europe. (ft.com)
- Israel is seeing more breakthrough cases with the Delta variant. (wsj.com)
Global
- The coronavirus is running rampant through South America. (wsj.com)
- Countries relying on Chinese vaccines are seeing more breakthrough infections. (nytimes.com)
- U.S. contributions to COVAX have been held up for various reasons. (fortune.com)
- American vaccine hesitancy is about privilege. (npr.org)
Masks
- Demand for N95 masks in the U.S. is in free fall. (bloomberg.com)
- Salon workers had air quality issues even before Covid. (vox.com)
- Why you still may want to wear a mask. (elemental.medium.com)
- Mask wearing works. (marginalrevolution.com)
Research
- How long haulers could help us understand other chronic diseases. (bloomberg.com)
- The risk of myocarditis is greater from Covid than from Covid vaccines. (washingtonpost.com)
- Researchers who shifted to studying SARS-CoV-2 are now considering a return to their original work. (statnews.com)
- How scientists identified a coronavirus outbreak from 20,000 years ago. (nytimes.com)
Treatments
- There's still no evidence that hydroxycholoroquine does anything for Covid. (washingtonpost.com)
- The evidence is still out on Vitamin D and Covid. (scientificamerican.com)
- There is still not much evidence on the efficacy of ivermectin. (gidmk.medium.com)
Earlier on Abnormal Returns
- Coronavirus links: near universal vaccination. (abnormalreturns.com)
- There's only one way through the pandemic tunnel. (abnormalreturns.com)
- The 'Swiss cheese model' and the importance of avoiding single points of failure in pandemic and life. (abnormalreturns.com)
- On the challenge of holding two competing thoughts on the pandemic in your head a the same time. (abnormalreturns.com)
